Knowledge attitude and practices of drug promotional literature: a clinician’s perspective

Kavita M. Jaiswal; Austina A.; Jijo Philip Abraham; Augustine V. Thomas

doi:10.18203/2319-2003.ijbcp20233195

Authors

Kavita M. Jaiswal Department of Pharmacology, Government Medical College and Hospital, Akola, Maharashtra, India
Austina A. Department of Pharmacology, Government Medical College and Hospital, Akola, Maharashtra, India
Jijo Philip Abraham Department of Pharmacology, Government Medical College and Hospital, Akola, Maharashtra, India
Augustine V. Thomas Department of Pharmacology, Government Medical College and Hospital, Akola, Maharashtra, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20233195

Keywords:

DPL, Questionnaire based study, Rational prescribing, MR

Abstract

Background: Promotion of drugs by pharmaceutical industries is fully regulated by drug regulators. Doctors are focus of intense marketing by representatives of pharmaceutical companies (MR). It is reported that very few physicians are equipped with the necessary skills and knowledge to critically assess the information delivered in drug promotional literature (DPL). Hence this study was carried out with the objective to determine knowledge, attitude and practices of doctors about the DPL

Methods: This was a questionnaire-based study population included clinicians working in a government set up and others doing private practice. Questionnaire was circulated online on social media platforms via Google forms.

Results: The 32.11% participants were aware of regulations and guidelines of DPL in India 80.7% participants searched for cost of medicine on DPL, 54.12% respondents perceive that the product claims made on DPL are balanced and supported by good evidence, 56.88% participants opined that their integrity is compromised by accepting gift from MR, 43.1% participants are exposed to drug advertisement through social media and 51.06% of them opined that their prescribing habits are influenced through this. Writing brand names while prescribing is significantly more in private practitioners as compared to doctors employed in government set up.

Conclusions: DPL serves to update the knowledge of the busy clinicians of the latest developments in the medical field. Quality check of drug promotion on social media is the need of the hour as this is influential. Private practitioners need to be addressed regarding enforced laws for rational prescribing.

Metrics

Metrics Loading ...

References

Criteria for Medicinal Drug Promotion, World Health Organization. Endorsed by the 33rd World Health Assembly. Resolution No. WHA21.41. Criteria for Medicinal Drug Promotion, World Health Organization; May 1986. Available at: http://apps.who.int/medicinedocs/en/d/Js16520e/6.html. Accessed on 15 August, 2023.

Jacob NT. Drug promotion practices: A review. Br J Clin Pharmacol. 2018;84(1):1659-67.

Trade, foreign policy, diplomacy and health, World Health Organization. Available at: http://www.who.int/trade/glossary. Accessed on 15 August, 2023.

Garje YA, Ghodke BV, Lalan HN, Senpaty S, Kumar R, Solunke S. Assessment of promotional drug literature using World Health Organization guidelines. Int J Ayurveda Res. 2014;4(2):3 5.

Phoolgen S, Kumar SA, Kumar RJ. Evaluation of the rationality of psychotropic drug promotional literatures in Nepal. J Drug Discov The. 2012;2(6):6‑8.

Zaki NM. Pharmacists’ and physicians’ perception and exposure to drug promotion: A Saudi study. Saudi Pharm J. 2014;22(6):528‑36.

Birhanu DW, Mehari GG, Tigist AB, Gidey MT, Belay YB, Tesfaye DM et al. Influence of Medical Representatives on Prescribing Practices in Mekelle, Northern Ethiopia. PLOS one. 2016;11(6):e0156795.

Sushil S, Neha A, Htet WM, Deepak RN, Venkat S. A study of perceptions and exposure of drug promotional literature among clinicians in a teaching hospital. Perspectives Clin Res. 2021;12(3).

Fischer MA, Keough ME, Baril JL. Prescribers and pharmaceutical representatives: why are we still meeting? J Gen Intern Med. 2009;24:795-801.

World Health Organization/Health Action International. Understanding and responding to pharmaceutical promotion- a practical guideline. 2010. Available at: http://www1.paho.org/hq/dmdocuments/2011/ drugpromotion-manual-CAP-3-090610.pdf. Accessed 10 June, 2023.

Lauren C, Yolanda E, Megan P, Megan AM. Social media use by physicians: a qualitative study of the new frontier of medicine. BMC Med Informatics Decision Making. 2016;16:91.

Shahrzad S, Long CM, Tahir MK. Interaction and medical inducement between pharmaceutical representatives and physicians: a meta- synthesis. J Pharmaceutical Policy Practice. 2016;9:37.

Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283(3):373-80.

Roy N, Madhiwalla N, Pai SA. Drug promotional practices in Mumbai: a qualitative study. Indian J Med Ethics. 2007;4(2):57-61.

Misra S, Ganzini L, Keepers G. Psychiatric resident and faculty views on and interactions with the pharmaceutical industry. Acad Psychiatry. 2010;34(2):102-8.

Saito S, Mukohara K, Bito S. Japanese practicing physicians’ relationships with pharmaceutical representatives: a national survey. PLoS One. 2010;5(8):e12193

Wang Y, Adelman RA. A study of interactions between pharmaceutical representatives and ophthalmology trainees. Am J Ophthalmol. 2009;148(4):619-22.

Lieb K, Brandtönies S. A survey of German physicians in private practice about contacts with pharmaceutical sales representatives. Dtsch Arztebl Int. 2010;107(22):392-8.

Medical Council of India: Circular on Generic Medicine; 2017. Available at: https://old.mciindia.org/circulars/Public-NoticeGeneric-Drugs-21.04.2017.pdf. Accessed on 5 June, 2023.

Press Trust of India. Narendra Modi hints at rules for doctors to prescribe generic drugs. The Hindu 2017. Available at: https://www.thehindu.com/sci-tech/health/narendra-modihints-at-rules-for-doctors-to-prescribe-generic-drugs/ article18076794.ece. Accessed on 5 June, 2023.